PATENT CLAIM ANALYSIS

Application Number: 15742166
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "464000"]

Abstract:
A rivaroxaban immediate release tablet comprising a non-ionic surfactant obtainable by using a dry process (i.e. no solvent is used during the manufacturing of the core tablet) which rapidly releases the drug as well as shows high stability and its fast and fed bioavailability is only attributable to the rivaroxaban behaviour.

Claim (Index 15):
A process to prepare tablets according to  claim 12 , which comprises the following steps:\n a) mixing rivaroxaban with at least the non-ionic surfactant, b) optionally adding the rest of the excipients and mixing, and c) compressing the resulting mixture into a tablet, wherein no liquid solvent is used in the process ending in step c).

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15536334', '15109170', '13034039', '12515986', '13143498']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6878096778031411
- 35 USC 102 Novelty (BERT): 0.4997156167849739
- Combined Prediction Score: 0.6690002717013244
- Mean Citation Score: 161.02946
- Max Citation Score: 177.48248
- Similarity Product: 107.24332552794937

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test